These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2142086)

  • 1. Inactivation of atrial natriuretic factor in mice in vivo: crucial role of enkephalinase (EC 3.4.24.11).
    Gros C; Souque A; Schwartz JC
    Eur J Pharmacol; 1990 Apr; 179(1-2):45-56. PubMed ID: 2142086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective protection of exogenous and endogenous atrial natriuretic factor by enkephalinase inhibitors in mice and humans.
    Lecomte JM; Baumer P; Lim C; Duchier J; Cournot A; Dussaule JC; Ardaillou R; Gros C; Chaignon B; Souque A
    Eur J Pharmacol; 1990 Apr; 179(1-2):65-73. PubMed ID: 2163851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan.
    Gros C; Souque A; Schwartz JC; Duchier J; Cournot A; Baumer P; Lecomte JM
    Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7580-4. PubMed ID: 2529543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diuretic and natriuretic responses in rats treated with enkephalinase inhibitors.
    Bralet J; Mossiat C; Lecomte JM; Charpentier S; Gros C; Schwartz JC
    Eur J Pharmacol; 1990 Apr; 179(1-2):57-64. PubMed ID: 2142087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of [125I]atrial natriuretic factor to mouse lung membranes in vivo: characterization and effects of peptidase inhibitors.
    Souque A; Gros C; Schwartz JC
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1373-8. PubMed ID: 1532034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enkephalinase (EC 3.4.24.11) inhibitors: protection of endogenous ANF against inactivation and potential therapeutic applications.
    Schwartz JC; Gros C; Lecomte JM; Bralet J
    Life Sci; 1990; 47(15):1279-97. PubMed ID: 2146457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of atrial natriuretic factor in mouse blood in vitro and in vivo: role of enkephalinase (EC 3.4.24.11).
    Gros C; Souque A; Schwartz JC
    Neuropeptides; 1990 Sep; 17(1):1-5. PubMed ID: 2148814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of enkephalinase inhibition in the living mouse, using [3H]acetorphan as a probe.
    De la Baume S; Brion F; Dam Trung Tuong M; Schwartz JC
    J Pharmacol Exp Ther; 1988 Nov; 247(2):653-60. PubMed ID: 3183961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed inhibitors of angiotensin-converting enzyme (EC 3.4.15.1) and enkephalinase (EC 3.4.24.11): rational design, properties, and potential cardiovascular applications of glycopril and alatriopril.
    Gros C; Noël N; Souque A; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Lecomte JM; Bralet J
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4210-4. PubMed ID: 1851998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiorphan-induced natriuresis in volume-expanded rats: roles of endogenous atrial natriuretic factor and kinins.
    Bralet J; Mossiat C; Gros C; Schwartz JC
    J Pharmacol Exp Ther; 1991 Sep; 258(3):807-11. PubMed ID: 1653839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the endopeptidase 24.11 in the disposition and metabolism of endogenous atrial natriuretic factor in the rabbit.
    Marleau S; Nguyen TT; Du Souich P; Bellemare M; De Lean A; Ong H
    Drug Metab Dispos; 1991; 19(1):194-9. PubMed ID: 1673398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sinorphan, an enkephalinase inhibitor, on plasma atrial natriuretic factor and sodium urinary excretion in cirrhotic patients with ascites.
    Dussaule JC; Grangé JD; Wolf JP; Lecomte JM; Gros C; Schwartz JC; Bodin F; Ardaillou R
    J Clin Endocrinol Metab; 1991 Mar; 72(3):653-9. PubMed ID: 1847706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific inhibitors of endopeptidase 24.11 inhibit the metabolism of atrial natriuretic peptides in vitro and in vivo.
    Olins GM; Krieter PA; Trapani AJ; Spear KL; Bovy PR
    Mol Cell Endocrinol; 1989 Feb; 61(2):201-8. PubMed ID: 2521834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of 125I-atrial natriuretic factor in anaesthetized rats. Effects of neutral endopeptidase inhibition with candoxatrilat and of ANF-C receptor blockade.
    Barclay PL; Bennett JA; Greengrass PM; Griffin A; Samuels GM; Shepperson NB
    Biochem Pharmacol; 1992 Sep; 44(6):1013-22. PubMed ID: 1417928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral excitatory effects of two enkephalinase inhibitors, acetorphan and thiorphan, and an enkephalin analogue, [D-Ala2-Met5]-enkephalinamide, on uterine motility in periparturient rats in vivo and in vitro.
    Adjroud O
    J Reprod Fertil; 1995 Jul; 104(2):181-6. PubMed ID: 7473405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimum AT1 receptor-neprilysin inhibition has superior cardioprotective effects compared with AT1 receptor blockade alone in hypertensive rats.
    Roksnoer LC; van Veghel R; de Vries R; Garrelds IM; Bhaggoe UM; Friesema EC; Leijten FP; Poglitsch M; Domenig O; Clahsen-van Groningen MC; Hoorn EJ; Jan Danser AH; Batenburg WW
    Kidney Int; 2015 Jul; 88(1):109-20. PubMed ID: 25830765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous atrial natriuretic factor after endopeptidase 24.11 inhibition by Thiorphan.
    Marleau S; Ong H; Brochu M; Yamaguchi N; de Lean A; du Souich P
    Peptides; 1990; 11(2):387-91. PubMed ID: 2141403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization and characterization of neutral metalloendopeptidase (EC 3.4.24.11), the degradative enzyme for atrial natriuretic peptide, in rat kidney using a radioiodinated neutral metalloendopeptidase inhibitor.
    Kanazawa M; Casley DJ; Sybertz EJ; Haslanger MF; Johnston CI
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1231-7. PubMed ID: 1534841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of C-ANF receptor and neutral endopeptidase on pharmacokinetics of ANF in rats.
    Chiu PJ; Tetzloff G; Romano MT; Foster CJ; Sybertz EJ
    Am J Physiol; 1991 Jan; 260(1 Pt 2):R208-16. PubMed ID: 1847022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.
    Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC
    J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.